The possibility of an annual vaccination for the coronavirus, as with the flu vaccine, was left open on Monday by the president of the National Vaccination Committee, Maria Theodoridou, during today’s briefing on the National Vaccination Plan for COVID-19.
“For the 4th installment one can only answer with speculation. The solution that would be satisfactory would be to need a 4th dose, but this 4th dose to be on time, to be as we do for the flu vaccination to consider the three doses as the basic vaccination and to make a dose in time as a repeat depending with the flu “.
For patients, he noted that a double vaccination may be needed after another 3 or 6 months and a second dose.
“Vaccination for Covid should not lead to delays and cancellations of the basic vaccination program for children,” said the chairwoman of the National Vaccination Committee.
“The vaccine in children contains 1/3 of the adult dose of antigen in two doses in 21 days. If a child becomes ill, the second dose is given after three months, something similar to what happens in adults. “The vaccination for Covid should not lead to postponements and cancellations of the basic program of vaccinations of children”, he noted characteristically, referring to the pediatrician about when the other vaccinations should be given to children.
“Vaccination protects a child’s health. The disease is mild from the beginning and remains mild, without different clinical manifestations over time, but there are small risks, such as the risk of multisystemic inflammatory syndrome in children (MIS-C), 1 case in 3,000 may have serious outcome “.
He noted that relevant research has just been published in Scotland on children and uncontrolled asthma. “The data for Scotland are for 752,000 children and the study found that children aged 5-17 were 3-6 times more likely to be hospitalized with Covid,” he said.
As for the side effects, she said that they are known to the parents, ie analogous to conventional vaccines, such as fever or local reaction at the injection site.
The administration of a third dose to those over 18 years of age has raised questions about whether and when we will have a third dose in minors.
To date, the 3rd dose has been approved for children with immunosuppression after a certain period of time.
He referred to the announcement of the WHO that characterizes the Omicron variant that it has a very high global risk but also to be milder than Delta, there will be problems in the hospitalization capital due to the high transmissibility.
“The disease was and remains mild without a different clinical expression over time, however there are risks,” warned Ms. Theodoridou.
Allergies are common in children, but the cases are very specific, and I consider a child unlikely to be allergic to the components of the vaccine, he explained.
Follow Skai.gr on Google News
and be the first to know all the news
.
